World's Best Scientists 2026 revealed!
VIEW LIST
Caicun Zhou

Caicun Zhou

Tongji University
China

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 103 7176 6739 76 72 717 61971

Caicun Zhou publications per year

The chart shows the history of publications by Caicun Zhou between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Caicun Zhou published across 39 years, from 1987 to 2025, averaging 18.3 papers a year. Output peaked at 80 publications in 2021. 49 of the 712 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 80. Peak 80 publications in 2021. 1987: 1 publication 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 1 publication 1996: 0 publications 1997: 1 publication 1998: 0 publications 1999: 0 publications 2000: 1 publication 2001: 0 publications 2002: 0 publications 2003: 0 publications 2004: 3 publications 2005: 7 publications 2006: 4 publications 2007: 15 publications 2008: 11 publications 2009: 15 publications 2010: 15 publications 2011: 13 publications 2012: 35 publications 2013: 32 publications 2014: 40 publications 2015: 56 publications 2016: 49 publications 2017: 70 publications 2018: 58 publications 2019: 61 publications 2020: 61 publications 2021: 80 publications 2022: 16 publications 2023: 18 publications 2024: 27 publications 2025: 22 publications
1987 2025

712 publications in total across all disciplines

View publications per year as a table
Caicun Zhou: publications per year, 1987 to 2025
Year Publications
1987 1
1988 0
1989 0
1990 0
1991 0
1992 0
1993 0
1994 0
1995 1
1996 0
1997 1
1998 0
1999 0
2000 1
2001 0
2002 0
2003 0
2004 3
2005 7
2006 4
2007 15
2008 11
2009 15
2010 15
2011 13
2012 35
2013 32
2014 40
2015 56
2016 49
2017 70
2018 58
2019 61
2020 61
2021 80
2022 16
2023 18
2024 27
2025 22
Total 712
Download as CSV

Caicun Zhou publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Caicun Zhou sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 701–720 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 717 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307 717
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Caicun Zhou D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Caicun Zhou sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 102–103 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630 103
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Caicun Zhou is affiliated with Tongji University in China and has a research focus primarily in medicine, with significant contributions to pulmonary and respiratory medicine, oncology, and cancer research. The scientist's work also touches on molecular biology and immunology as subfields of study.

Their research frequently covers topics such as lung cancer treatments and mutations, cancer immunotherapy and biomarkers, lung cancer diagnosis and treatment, cancer genomics and diagnostics, lung cancer research studies, colorectal cancer treatments and studies, and HER2/EGFR in cancer research.

Recent notable publications include:

  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial (2021) - The Lancet
  • Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial (2020) - The Lancet Respiratory Medicine
  • Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial (2021) - Journal of Thoracic Oncology
  • Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer (2021) - JAMA Oncology
  • Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial (2023) - Annals of Oncology

Caicun Zhou has collaborated with several frequent co-authors including:

  • Shengxiang Ren
  • Tao Jiang
  • Fengying Wu
  • Enriqueta Felip
  • Ying Cheng

The researcher's work has appeared primarily in several key publication venues, demonstrating a focus on clinical oncology and thoracic oncology. These include:

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Lung Cancer
  • Translational Lung Cancer Research
  • SSRN Electronic Journal

Best Publications

  • Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

    Jean-Charles Soria;Yuichiro Ohe;Johan Vansteenkiste;Thanyanan Reungwetwattana

  • Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

    Caicun Zhou;Yi Long Wu;Gongyan Chen;Jifeng Feng

  • Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

    Tony S.K. Mok;Yi Long Wu;Iveta Kudaba;Dariusz M. Kowalski

  • Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

    Suresh S Ramalingam;Johan Vansteenkiste;David Planchard;Byoung Chul Cho

  • Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

    Luis Paz-Ares;Mikhail Dvorkin;Yuanbin Chen;Niels Reinmuth

  • Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

    Yi-Long Wu;Caicun Zhou;Cheng-Ping Hu;Jifeng Feng

  • Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

    James Chih Hsin Yang;Yi Long Wu;Martin Schuler;Martin Sebastian

  • Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

    Vincent A. Miller;Vincent A. Miller;Vera Hirsh;Jacques Cadranel;Yuh Min Chen

  • Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.

    James C.H. Yang;Lecia V. Sequist;Sarayut Lucien Geater;Chun Ming Tsai

  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.

    Enriqueta Felip;Nasser Altorki;Caicun Zhou;Tibor Csőszi

  • First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

    Y.-L. Wu;C. Zhou;C.-K. Liam;G. Wu

  • Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

    Daniel B. Costa;Alice T. Shaw;Sai-Hong I. Ou;Benjamin J. Solomon

  • CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

    Thanyanan Reungwetwattana;Kazuhiko Nakagawa;Byoung Chul Cho;Manuel Cobo

  • Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy

    Tony S.K. Mok;Yi-Long Wu;Jin Soo Lee;Chong-Jen Yu

  • Final overall survival results from a randomised, Phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)

    Caicun Zhou;Y. L. Wu;G. Chen;J. Feng

  • Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial

    Yuankai Shi;Li Zhang;Xiaoqing Liu;Caicun Zhou

  • Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

    Fengying Wu;Jue Fan;Yayi He;Anwen Xiong

  • Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC): a double-blind, randomised, phase 3 trial.

    Roy S Herbst;Yan Sun;Wilfried E E Eberhardt;Paul Germonpré

  • Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.

    Jonathan W Goldman;Mikhail Dvorkin;Yuanbin Chen;Niels Reinmuth

  • Role of IL-2 in cancer immunotherapy.

    Tao Jiang;Caicun Zhou;Shengxiang Ren

Frequent Co-Authors

Yi-Long Wu
Yi-Long Wu Guangdong Provincial People’s Hospital
Li Zhang
Li Zhang Sun Yat-sen University
Tony Mok
Tony Mok Chinese University of Hong Kong
Jifeng Feng
Jifeng Feng Nanjing Medical University
James Chih-Hsin Yang
James Chih-Hsin Yang National Taiwan University
Lei Wang
Lei Wang University of Wollongong
Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology
Kefeng Cai
Kefeng Cai Tongji University
Yongqian Shu
Yongqian Shu Nanjing Medical University
Lecia V. Sequist
Lecia V. Sequist Harvard University

External Links

Personal website of Caicun Zhou

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring diverse healthcare career options? Online degrees offer flexibility and can help launch or advance your medical career. Beyond a traditional MD, there are a variety of paths with a strong job outlook. For those interested in mental health services, online pmhnp programs enable nurses to become Psychiatric Mental Health Nurse Practitioners quickly and conveniently, often while continuing to work.

Healthcare leadership and management are thriving fields as well. If you aspire to run medical facilities or lead teams, consider online healthcare administration programs. These programs help build business skills tailored to the healthcare environment.

Students seeking to maximize value can find online mha programs affordable for developing executive skills without breaking the bank. For advanced nursing professionals, the cheapest online dnp programs make it possible to obtain a terminal nursing degree with lower tuition costs.

Choosing the right online program can accelerate your healthcare career and help you specialize in high-demand fields—no matter where you’re starting from.

Best Scientists Citing Caicun Zhou

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 154

James Chih-Hsin Yang

James Chih-Hsin Yang

National Taiwan University

Publications: 112

Tony Mok

Tony Mok

Chinese University of Hong Kong

Publications: 107

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 97

Li Zhang

Li Zhang

Sun Yat-sen University

Publications: 89

Kazuhiko Nakagawa

Kazuhiko Nakagawa

Kindai University

Publications: 84

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 77

Myung-Ju Ahn

Myung-Ju Ahn

Sungkyunkwan University

Publications: 76

Isamu Okamoto

Isamu Okamoto

Kyushu University

Publications: 68

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 67

Suresh S. Ramalingam

Suresh S. Ramalingam

Emory University

Publications: 63

Silvia Novello

Silvia Novello

University of Turin

Publications: 63

Lecia V. Sequist

Lecia V. Sequist

Harvard University

Publications: 61

Tetsuya Mitsudomi

Tetsuya Mitsudomi

Kindai University

Publications: 61

Martin Reck

Martin Reck

LungenClinic Grosshansdorf

Publications: 61

Keunchil Park

Keunchil Park

The University of Texas MD Anderson Cancer Center

Publications: 60

Trending Scientists

Nguyen Van Hieu

Nguyen Van Hieu

Phenikaa University

Antoine H.F.M. Peters

Antoine H.F.M. Peters

Friedrich Miescher Institute

Mostafa M. Rady

Mostafa M. Rady

Fayoum University

Casey Paquola

Casey Paquola

Forschungszentrum Jülich

Noshin Omar

Noshin Omar

Vrije Universiteit Brussel

Sophie Bergeron

Sophie Bergeron

University of Montreal

Edward M. Scolnick

Edward M. Scolnick

Broad Institute

John G. Breslin

John G. Breslin

University of Galway

M. Frans Kaashoek

M. Frans Kaashoek

MIT

Claude Lamy

Claude Lamy

University of Montpellier

James J. Vredenburgh

James J. Vredenburgh

Yale School of Medicine

Amil M. Shah

Amil M. Shah

Harvard University

Olivier R. Busch

Olivier R. Busch

University of Amsterdam

Marco Valgimigli

Marco Valgimigli

University of Bern

Josip Pečarić

Josip Pečarić

University of Zagreb

Tadeusz Uhl

Tadeusz Uhl

AGH University of Science and Technology

Related Medicine Rankings & Guides

2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs
2027 Best Online Nursing Degree Programs

2027 Best Online Nursing Degree Programs
2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs
2027 Most Affordable LPN/LVN to BSN Online Bridge Programs

2027 Most Affordable LPN/LVN to BSN Online Bridge Programs
2027 Best Online Master of Health Administration (MHA) Programs

2027 Best Online Master of Health Administration (MHA) Programs
2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus
2027 Easiest MPH Online Programs to Get Into

2027 Easiest MPH Online Programs to Get Into
2027 Best Online Associate in Health Sciences

2027 Best Online Associate in Health Sciences
2027 Healthcare Degree Programs You Can Earn in 2 Years or Less

2027 Healthcare Degree Programs You Can Earn in 2 Years or Less
2027 Best Online Exercise Science Degree Programs

2027 Best Online Exercise Science Degree Programs
2027 Fastest Online Pharmacy Technician Certificate Programs

2027 Fastest Online Pharmacy Technician Certificate Programs
2027 Fastest Online Exercise Science Degree Programs

2027 Fastest Online Exercise Science Degree Programs
2027 Most Affordable Online DNP Programs

2027 Most Affordable Online DNP Programs
2027 Best Online Bachelor’s Degrees in Nutritional Science Programs

2027 Best Online Bachelor’s Degrees in Nutritional Science Programs
September 2027 Best Nursing Certifications to Consider

September 2027 Best Nursing Certifications to Consider
2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 Best Online MSN Programs Without Clinicals

2027 Best Online MSN Programs Without Clinicals
2026 Easiest Accelerated BSN Programs to Get Into

2026 Easiest Accelerated BSN Programs to Get Into
2027 Most Affordable Online Associate’s Degree in Radiology

2027 Most Affordable Online Associate’s Degree in Radiology
2027 Easiest Nurse Practitioner Degree Programs

2027 Easiest Nurse Practitioner Degree Programs

Recently Published Articles

2027 Different Types of Advertising Degrees and Their Salaries

2027 Different Types of Advertising Degrees and Their Salaries
2027 Do Employers Pay for Medical Assisting Degrees: Tuition Reimbursement and Sponsorship Options

2027 Do Employers Pay for Medical Assisting Degrees: Tuition Reimbursement and Sponsorship Options
2027 How to Become an Art Teacher in Wisconsin: Requirements & Certification

2027 How to Become an Art Teacher in Wisconsin: Requirements & Certification
2027 Online Homeland Security Doctorate Programs for Licensed Professionals

2027 Online Homeland Security Doctorate Programs for Licensed Professionals
2027 Online Population Health Doctorate Programs for Licensed Professionals

2027 Online Population Health Doctorate Programs for Licensed Professionals
2027 Most Flexible Careers You Can Pursue With a Criminology Degree: Remote, Hybrid, and Freelance Paths

2027 Most Flexible Careers You Can Pursue With a Criminology Degree: Remote, Hybrid, and Freelance Paths
2027 Best Online Logistics Degree Programs

2027 Best Online Logistics Degree Programs
2027 Arcadia University Transfer Credit Policy: How Many Credits Can You Bring?

2027 Arcadia University Transfer Credit Policy: How Many Credits Can You Bring?
2027 Military-Friendly Online Marriage & Family Counseling Master's Degree Programs: Benefits, Accreditation & Career Outcomes

2027 Military-Friendly Online Marriage & Family Counseling Master's Degree Programs: Benefits, Accreditation & Career Outcomes
2027 What Prerequisites Do You Need for an Occupational Therapy Master's Degree? Entry Requirements, Credits & Eligibility Rules

2027 What Prerequisites Do You Need for an Occupational Therapy Master's Degree? Entry Requirements, Credits & Eligibility Rules
2027 Are There Any One-Year Online Applied Science Degree Programs Worth Considering?

2027 Are There Any One-Year Online Applied Science Degree Programs Worth Considering?
2027 How to Become a Substance Abuse Counselor in Texas

2027 How to Become a Substance Abuse Counselor in Texas
2027 Most Affordable Bachelor's Degrees for Students Who Need Transfer Credit

2027 Most Affordable Bachelor's Degrees for Students Who Need Transfer Credit
2027 Competency-Based Online Biology Master's Degrees

2027 Competency-Based Online Biology Master's Degrees
2027 Is an Exercise Science Degree Better Than Experience Alone? Salary, Hiring, and Career Growth Compared

2027 Is an Exercise Science Degree Better Than Experience Alone? Salary, Hiring, and Career Growth Compared
2027 Most Affordable Online Gerontology Master’s Degree Programs

2027 Most Affordable Online Gerontology Master’s Degree Programs
2027 Best Accredited Online Taxation Bachelor's Degree Programs

2027 Best Accredited Online Taxation Bachelor's Degree Programs
2027 Business Salary by State Report

2027 Business Salary by State Report
2027 How to Become a Substitute Teacher in Wisconsin

2027 How to Become a Substitute Teacher in Wisconsin
2027 Neurologist vs. Psychiatrist: Explaining the Difference

2027 Neurologist vs. Psychiatrist: Explaining the Difference
2027 CMA vs RMA vs CCMA: Explaining The Difference

2027 CMA vs RMA vs CCMA: Explaining The Difference